Next Article in Journal
3-(4-Fluorophenyl)-N-[4-(4-furan-2-yl-1-oxo-2,3,7-triazaspiro[4.5]dec-3-en-2-yl)phenyl]propionamide Hydrochloride
Previous Article in Journal
N-(3,4-Dimethoxyphenyl)-4-oxo-2,3,7-triazaspiro[4.5]dec-1-ene-1-carboxamide Hydrochloride
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

N1-((1H-Indazol-5-yl)methylene)-N2-(2-((2-((2-(((1H-indazol-6-yl)methylene)amino)ethyl)amino)ethyl)amino)ethyl)ethane-1,2-diamine

by
Cristina Núñez
1,*,
Javier Fernández-Lodeiro
2,
Adrián Fernández-Lodeiro
2,
Emília Bértolo
3,
José Luis Capelo
1,2 and
Carlos Lodeiro
1,2,*
1
REQUIMTE, Chemistry Department, Faculty of Science and Technology, University Nova of Lisbon, 2829-516, Monte de Caparica, Portugal
2
BIOSCOPE Group, Faculty of Science, Physical-Chemistry Department, Ourense Campus, University of Vigo, 32004, Ourense, Spain
3
Ecology Research Group, Department of Geographical and Life Sciences, Canterbury Christ Church University. Canterbury, Kent. CT1 1QU, UK
*
Authors to whom correspondence should be addressed.
Molbank 2012, 2012(3), M770; https://doi.org/10.3390/M770
Submission received: 18 June 2012 / Accepted: 31 July 2012 / Published: 9 August 2012

Abstract

:
One novel molecular emissive probe L has been synthesized by classical Schiff-base reaction between 1H-indazole-6-carboxaldehyde and tetraethylenepentamine. The structure of compound L was confirmed by melting point, elemental analysis, ESI-MS spectrometry and by IR and 13C-NMR and 1H-NMR spectroscopy.

Graphical Abstract

Indazole ring systems have an interesting chemistry, which has been used in biology, catalysis, and medicinal chemistry [1]. Although rare in nature [2], indazoles exhibit a variety of biological activities such as HIV protease inhibition [3,4,5], antiarrhythmic and analgesic activities [6], antitumor activity [7,8], and antihypertensive properties [9]. Furthermore, antimicrobial and antineoplastic activities have also been shown to be associated with certain indazole derivatives [10].
As a part of our ongoing research into the design and synthesis of novel organic molecular probes, luminescent materials and MALDI-TOF-MS matrices [11,12,13,14], here we report the synthesis and characterization of a new Schiff-base compound L containing two indazole units linked by a flexible polyethylene bridged (See scheme 1).

Experimental

A solution of 1H-indazole-6-carboxaldehyde (0.254 g, 1.718 mmol) in absolute ethanol (10 mL) was added dropwise to a refluxing solution of tetraethylenepentamine (0.162 g, 0.859 mmol) in the same solvent (30 mL) (See scheme 1). The resulting solution was gently refluxed with magnetic stirring for ca. 4 h. The colour changed from yellow to brown. After that time, the mixture was allowed to cool to room temperature and a brown powder precipitate was formed; this was then filtered off, washed with cold absolute ethanol and cold diethyl ether and dried under vacuum. The resulting compound was characterized as L follow purification by column chromatography.
Melting point: 163–165 °C.
Yield: 382 mg (L) (93%).
ESI-MS: m/z (rel. int%): 446.27 (100) ([L+H]+.
1H-NMR (CDCl3) (L): δ = 12.1 (s, 2H, N–H); 8.4 (s, 2H, N=C–H); 8.2–7.0 (m, 6H, C-Har); 3.9–2.1 (m, 16H, CH2); 1.5 (s, 3H, NH) ppm.
13C-NMR (CDCl3) (L): δ = 160.5; 150.3; 147.2; 133.6; 131.2; 127.9; 126.1; 125.0; 124.2; 119.7; 112.3; 110.4; 56.2; 50.6; 49.8.
IR (cm−1) (L): 3051 (C–H, Ar), 1638 (C=N, Imine), 1618, 1593, 1562 and 1509 (C=C, Ar).
Elemental analysis: Calcd for C24H37N9O3: C, 57.70; H, 7.45; N, 25.25. Found (L): C, 58.00; H, 7.15; N, 25.00.
Uv-vis (CHCl3), [L] = 1.00 × 10−5 M, λmax 275 and 324 nm.
Fluorescence Emission (CHCl3); [L] = 1.00 × 10−5): λmax 427 nm.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgements

We are grateful to Xunta de Galicia (Spain) for projects 09CSA043383PR and 10CSA383009PR (Biomedicine) and to the Scientific Association ProteoMass for financial support. C.N. thanks the Fundação para a Ciência e a Tecnologia/FEDER (Portugal/EU) programme postdoctoral contract SFRH/BPD/65367/2009. J.F.L. thanks Xunta de Galicia (Spain) for a research contract by project 09CSA043383PR in Biomedicine. J.L.C. and C.L. thank Xunta de Galicia for the Isidro Parga Pondal Research program.

References and Notes

  1. Sather, A.C.; Berryman, O.B.; Rebek, J., Jr. Synthesis of Fused Indazole Ring Systems and Application to Nigeglanine Hydrobromide. Org. Lett. 2012, 14, 1600–1603. [Google Scholar] [CrossRef] [PubMed]
  2. Ali, Z.; Ferreira, D.; Carvalho, P.; Avery, M.A.; Khan, I.A. Nigellidine-4-O-sulfite, the First Sulfated Indazole-Type Alkaloid from the Seeds of Nigella sativa. J. Nat. Prod. 2008, 71, 1111–1112. [Google Scholar] [CrossRef] [PubMed]
  3. Han, W.; Pelletier, J.C.; Hodge, C.N. Tricyclic ureas: A new class of HIV-1 protease inhibitor. Bioorg. Med. Chem. Lett. 1998, 8, 3615–3620. [Google Scholar] [CrossRef]
  4. Patel, M.; Rodgers, J.D.; McHugh, R.J., Jr.; Johnson, B.L.; Cordova, B.C.; Klaba, R.M.; Bacheler, L.T.; Erickson-Viitanen, S.; Ko, S.S. Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2′ substituents. Bioorg. Med. Chem. Lett. 1999, 9, 3217–3220. [Google Scholar] [CrossRef]
  5. Sun, J.-H.; Teleha, C.A.; Yan, J.-S.; Rodgers, J.D.; Nugiel, D.A. Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole. J. Org. Chem. 1997, 62, 5627–5629. [Google Scholar] [CrossRef]
  6. Mosti, L.; Menozzi, G.; Fossa, P.; Filippelli, W.; Gessi, S.; Rinaldi, B.; Falcone, G. Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents. Arzneimittelforschung 2000, 50, 963–972. [Google Scholar] [PubMed]
  7. Jakupec, M.A.; Reisner, E.; Eichinger, A.; Pongratz, M.; Arion, V.B.; Galanski, M.; Hartinger, C.G.; Keppler, B.K. Redox-Active Antineoplastic Ruthenium Complexes with Indazole: Correlation of in Vitro Potency and Reduction Potential. J. Med. Chem. 2005, 48, 2831–2837. [Google Scholar] [CrossRef] [PubMed]
  8. Showalter, H.D.H.; Angelo, M.M.; Berman, E.M.; Kanter, G.D.; Ortwine, D.F.; Ross-Kesten, S.G.; Sercel, A.D.; Turner, W.R.; Werbel, L.M.; Worth, D.F.; et al. Benzothiopyranoindazoles, a New Class of Chromophore Modified Anthracenedione Anticancer Agents. Synthesis and Activity against Murine Leukemias. J. Med. Chem. 1988, 31, 1527–1539. [Google Scholar] [CrossRef] [PubMed]
  9. Goodman, K.B.; Cui, H.; Dowdell, S.E.; Gaitanopoulos, D.E.; Ivy, R.L.; Sehon, C.A.; Stavenger, R.A.; Wang, G.Z.; Viet, A.Q.; Xu, W.; et al. Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors. J. Med. Chem. 2007, 50, 6–9. [Google Scholar] [CrossRef] [PubMed]
  10. Raffa, D.; Daidone, G.; Maggio, B.; Schillaci, D.; Plescia, F. Synthesis and Antiproliferative Activity of Novel 3-(Indazol-3-yl)-quinazolin-4(3H)-one and 3-(Indazol-3-yl)-benzotriazin-4(3H)-one Derivatives. Arch. Pharm. Pharm. Med. Chem. 1999, 332, 317–320. [Google Scholar] [CrossRef]
  11. Lodeiro, C.; Pina, F. Luminescent and chromogenic molecular probes based on polyamines and related compounds. Coord. Chem. Rev. 2009, 253, 1353–1385. [Google Scholar] [CrossRef]
  12. Lodeiro, C.; Capelo, J.L.; Mejuto, J.C.; Oliveira, E.; Santos, H.M.; Pedras, B.; Nuñez, C. Light and colour as analytical detection tools: A journey into the periodic table using polyamines to bio-inspired systems as chemosensors. Chem. Soc. Rev. 2010, 39, 2948–2976. [Google Scholar] [CrossRef] [PubMed]
  13. Bastista, R.M.F.; Oliveira, E.; Costa, S.P.G.; Lodeiro, C.; Raposo, M.M.M. Imidazo-benzo-15-crwon-5 ethers bearing arylthienyl and bithienyl moieitis as novel fluorescent chemosensor for Pd(II) and Cu(II). Tetrahedron 2011, 67, 7106–7113. [Google Scholar] [CrossRef] [Green Version]
  14. Fernández-Lodeiro, J.; Nuñez, C.; Carreira, R.; Santos, H.M.; López, C.S.; Mejuto, J.C.; Capelo, J.L.; Lodeiro, C. Novel versatile imine-enamine chemosensor based on 6-nitro-4-oxo-4H-chromene for ion detection in solution, solid and gas phase: Synthesis, emission, computational and MALDI-TOF-MS studies. Tetrahedron 2011, 67, 326–333. [Google Scholar] [CrossRef]
Scheme 1. Schematic representation of compound L.
Scheme 1. Schematic representation of compound L.
Molbank 2012 m770 sch001

Share and Cite

MDPI and ACS Style

Núñez, C.; Fernández-Lodeiro, J.; Fernández-Lodeiro, A.; Bértolo, E.; Capelo, J.L.; Lodeiro, C. N1-((1H-Indazol-5-yl)methylene)-N2-(2-((2-((2-(((1H-indazol-6-yl)methylene)amino)ethyl)amino)ethyl)amino)ethyl)ethane-1,2-diamine. Molbank 2012, 2012, M770. https://doi.org/10.3390/M770

AMA Style

Núñez C, Fernández-Lodeiro J, Fernández-Lodeiro A, Bértolo E, Capelo JL, Lodeiro C. N1-((1H-Indazol-5-yl)methylene)-N2-(2-((2-((2-(((1H-indazol-6-yl)methylene)amino)ethyl)amino)ethyl)amino)ethyl)ethane-1,2-diamine. Molbank. 2012; 2012(3):M770. https://doi.org/10.3390/M770

Chicago/Turabian Style

Núñez, Cristina, Javier Fernández-Lodeiro, Adrián Fernández-Lodeiro, Emília Bértolo, José Luis Capelo, and Carlos Lodeiro. 2012. "N1-((1H-Indazol-5-yl)methylene)-N2-(2-((2-((2-(((1H-indazol-6-yl)methylene)amino)ethyl)amino)ethyl)amino)ethyl)ethane-1,2-diamine" Molbank 2012, no. 3: M770. https://doi.org/10.3390/M770

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop